Pharming Group schedules its Q2 and H1 2026 earnings release for July 30, inviting investors to a conference call
Executive summary: Pharming Group set July 30, 2026 as the date to report its Q2 and H1 2026 financial results and to host a conference call/webcast on the same day. The release will give investors concrete data on revenue, earnings and pipeline progress, allowing them to reassess the company’s valuation and near‑term outlook.
Who is involved: Pharming Group (the reporting company), its investor relations team, and the broader shareholder and analyst community.
Likely next: On July 30, 2026 the company will publish the financial statements, release a press release, and conduct the scheduled conference call to discuss the results.
Pharming Group has announced that it will publish its second‑quarter and first‑half 2026 financial results on July 30, 2026, followed by a live conference call and webcast. The announcement is a routine quarterly update that provides the market with the latest performance data on the company’s specialty protein portfolio. No forward guidance or material events were disclosed in the notice, making the release primarily a source of factual financial information for shareholders and analysts.
Timeline
- — Pharming Group to report second quarter and first half 2026 financial results and provide business update on July 30 (GlobeNewswire)
Analysis — what this means
Likely next events
- July 30, 2026: Pharming Group publishes Q2/H1 2026 financial results and hosts a conference call.
Sectors affected
- Biopharmaceuticals
- Specialty proteins
Historical parallels
- Pharming Group Q1 2026 results announcement (April 2026)
- Pharming Group FY 2025 results release (February 2026)